ArticleJournal of Alzheimer's disease : JAD2020
Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment.
Article in Journal of Alzheimer's disease : JAD, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 23 citations in OpenAlex.
- Diagnostic Accuracy of Touchscreen-Based Tests for Mild Cognitive Disorders: A Systematic Review and Meta-Analysis.Diagnostics (Basel, Switzerland) · 2025Review
- Impact of DL-3-n-Butylphthalide on Progression in Alzheimer's Disease: A Retrospective Cohort Analysis.Neuropsychiatric disease and treatment · 2025Article
- The Potential of Automated Assessment of Cognitive Function Using Non-Neuroimaging Data: A Systematic Review.Journal of clinical medicine · 2024Review
- Toward better understanding and management of chemobrain: the potential utilities of the MemTrax memory test.BMC women's health · 2024Article
- Applications of Artificial Intelligence in the Neuropsychological Assessment of Dementia: A Systematic Review.Journal of personalized medicine · 2024Review
- Episodic memory assessment: effects of sex and age on performance and response time during a continuous recognition task.Frontiers in human neuroscience · 2024Article
- Toward digitally screening and profiling AD: A GAMLSS approach of MemTrax in China.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Article
- Validity and Reliability Study of Online Cognitive Tracking Software (BEYNEX).Journal of Alzheimer's disease reports · 2024Article
- Using MemTrax memory test to screen for post-stroke cognitive impairment after ischemic stroke: a cross-sectional study.Frontiers in human neuroscience · 2023Article
- Mild Cognitive Impairment: Data-Driven Prediction, Risk Factors, and Workup.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2023Article
- Classification and Interpretability of Mild Cognitive Impairment Based on Resting-State Functional Magnetic Resonance and Ensemble Learning.Computational intelligence and neuroscience · 2022Article
- Correctness and response time distributions in the MemTrax continuous recognition task: Analysis of strategies and a reverse-exponential model.Frontiers in aging neuroscience · 2022Article
- PET Imaging of Tau Pathology and Amyloid-β, and MRI for Alzheimer's Disease Feature Fusion and Multimodal Classification.Journal of Alzheimer's disease : JAD · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe widespread incidence and prevalence of Alzheimer's disease and mild cognitive impairment (MCI) has prompted an urgent call for research to validate early detection cognitive screening and assessment.
objectiveOur primary research aim was to determine if selected MemTrax performance metrics and relevant demographics and health profile characteristics can be effectively utilized in predictive models developed with machine learning to classify cognitive health (normal versus MCI), as would be indicated by the Montreal Cognitive Assessment (MoCA).
methodsWe conducted a cross-sectional study on 259 neurology, memory clinic, and internal medicine adult patients recruited from two hospitals in China. Each patient was given the Chinese-language MoCA and self-administered the continuous recognition MemTrax online episodic memory test on the same day. Predictive classification models were built using machine learning with 10-fold cross validation, and model performance was measured using Area Under the Receiver Operating Characteristic Curve (AUC). Models were built using two MemTrax performance metrics (percent correct, response time), along with the eight common demographic and personal history features.
resultsComparing the learners across selected combinations of MoCA scores and thresholds, Naïve Bayes was generally the top-performing learner with an overall classification performance of 0.9093. Further, among the top three learners, MemTrax-based classification performance overall was superior using just the top-ranked four features (0.9119) compared to using all 10 common features (0.8999).
conclusionMemTrax performance can be effectively utilized in a machine learning classification predictive model screening application for detecting early stage cognitive impairment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.